バイオニックアイ市場規模、シェア、成長分析、タイプ別、技術別、プロテーゼシステム別、エンドユーザー別、地域別 - 産業予測、2025～2032年

バイオニックアイ市場規模は2023年に3億150万米ドルとなり、予測期間（2025-2032年）のCAGRは12.88%で、2024年の3億4,033万米ドルから2032年には8億9,710万米ドルに成長すると予測されています。

世界のバイオニックアイ市場は、網膜疾患の有病率の上昇、人口の高齢化、技術の進歩に後押しされ、力強い成長を遂げています。網膜疾患の罹患率の増加は、視力障害の影響をますます受ける人口層に対応する革新的な視力回復ソリューションの需要を増大させています。最近のバイオニックアイ技術の革新により、植え込み型装置と外部カメラを統合し、視力と全体的な性能を向上させる洗練されたシステムが誕生しました。しかし、バイオニック・インプラントや外科手術に伴う高額な費用が、特に発展途上地域におけるアクセシビリティを制限しているなど、課題も残っています。さらに、これらのデバイスの長期的な安全性と有効性は依然として調査中であり、規制当局の承認取得と多様な償還政策を乗り切ることが、市場拡大のさらなるハードルとなっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

バイオニックアイ市場規模：タイプ別

• 市場概要
• 外眼
• 移植眼

バイオニックアイ市場規模：プロテーゼシステム別

• 市場概要
• Argus II
• Alpha IMS
• Alpha AMS
• IRIS II
• その他

バイオニックアイ市場規模：技術別

• 市場概要
• 電子
• 機械

バイオニックアイ市場規模：エンドユーザー別

• 市場概要
• 病院
• 眼科クリニック
• その他

バイオニックアイ市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Second Sight Medical Products, Inc.（USA）
• Pixium Vision（France）
• Monash Vision Group（Australia）
• Nano Retina Ltd.（Israel）
• Optobionics Corporation（Japan）
• Nidek Co., Ltd.（Japan）
• Bionic Vision Technologies（Australia）
• iBionics（USA）
• Vivani Medical Inc.（USA）
• MetaModal LLC（USA）
• Biomedical Technologies S.L.（Spain）

結論と推奨事項

Bionic Eye Market size was valued at USD 301.5 Million in 2023 and is poised to grow from USD 340.33 Million in 2024 to USD 897.1 Million by 2032, growing at a CAGR of 12.88% during the forecast period (2025-2032).

The global bionic eye market is witnessing robust growth, fueled by the rising prevalence of retinal diseases, an aging population, and technological advancements. Increased incidence of retinal disorders amplifies the demand for innovative vision restoration solutions, catering to a demographic increasingly affected by vision impairments. Recent innovations in bionic eye technology have led to the creation of sophisticated systems that integrate implantable devices with external cameras, enhancing visual acuity and overall performance. However, challenges persist, including high costs associated with bionic implants and surgical procedures, which limit accessibility, especially in developing regions. Additionally, the long-term safety and efficacy of these devices remain under investigation, while obtaining regulatory approvals and navigating diverse reimbursement policies present further hurdles to market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bionic Eye market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bionic Eye Market Segmental Analysis

Global Bionic Eye Market is segmented by type, technology, end users, prosthesis system and region. Based on type, the market is segmented into external eye and implanted eye. Based on technology, the market is segmented into electronic and mechanical. Based on prosthesis system, the market is segmented into Argus II, Alpha IMS, Alpha AMS, IRIS II, and Others. Based on end users, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bionic Eye Market

The bionic eye market is significantly driven by the growing prevalence of retinal diseases, including conditions like retinitis pigmentosa and age-related macular degeneration. As more individuals experience severe vision impairments or blindness attributable to these retinal disorders, there is an escalating demand for bionic eye technology as a viable solution for vision restoration. This increasing patient population creates a compelling need for innovative interventions, thus propelling advancements and investments in bionic eye technologies. With the potential to transform lives through improved vision capabilities, the bionic eye sector is positioned for substantial growth in response to this rising healthcare challenge.

Restraints in the Bionic Eye Market

Restraints in the Bionic Eye market primarily stem from the high expenses associated with bionic eye implants and the surgical procedures required for their installation. This elevated cost acts as a substantial hindrance to market expansion, as it restricts access to these innovative devices, particularly in areas with underdeveloped healthcare systems or limited reimbursement options. The financial burdens related to affordability and reimbursement pose significant challenges that discourage the widespread adoption of bionic eye technology. Consequently, these factors contribute to a slower integration of bionic eye solutions across various markets, limiting their potential benefits for those in need.

Market Trends of the Bionic Eye Market

The bionic eye market is witnessing a significant trend towards miniaturization and implantable designs, enhancing both functionality and patient experience. As devices become more compact, they facilitate easier surgical implantation, resulting in heightened comfort for users. Innovations in wireless power and data transmission are transforming the landscape of bionic eye technology, allowing for seamless integration into the human body. This shift not only caters to patient demand for discreet solutions but also propels advancements in vision restoration capabilities, indicating a robust future for the bionic eye market as it aligns with the broader movement towards personalized and minimally invasive medical devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bionic Eye Market Size by Type & CAGR (2025-2032)

• Market Overview
• External Eye
• Implanted Eye

Global Bionic Eye Market Size by Prosthesis System & CAGR (2025-2032)

• Market Overview
• Argus II
• Alpha IMS
• Alpha AMS
• IRIS II
• Others

Global Bionic Eye Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Electronic
• Mechanical

Global Bionic Eye Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ophthalmic Clinics
• Others

Global Bionic Eye Market Size & CAGR (2025-2032)

• North America (Type, Prosthesis System, Technology, End Users)
  • US
  • Canada
• Europe (Type, Prosthesis System, Technology, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Prosthesis System, Technology, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Prosthesis System, Technology, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Prosthesis System, Technology, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Second Sight Medical Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pixium Vision (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monash Vision Group (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Retina Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optobionics Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionic Vision Technologies (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iBionics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivani Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MetaModal LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedical Technologies S.L. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations